Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-25-014210
Filing Date
2025-09-25
Accepted
2025-09-25 20:59:14
Documents
1
Period of Report
2025-09-23

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-70866.html 4  
1 PRIMARY DOCUMENT marketforms-70866.xml 4 18574
  Complete submission text file 0001214659-25-014210.txt   20105
Mailing Address 11411 SOUTHERN HIGHLANDS PARKWAY SUITE 190 LAS VEGAS NV 89141
Business Address
AULT MILTON C III (Reporting) CIK: 0001212502 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-40483 | Film No.: 251345231

Mailing Address 480 PEACHTREE ROAD NE, SECOND FLOOR SUITE 103 ATLANTA GA 30326
Business Address 480 PEACHTREE ROAD NE, SECOND FLOOR SUITE 103 ATLANTA GA 30326 844-722-6333
Alzamend Neuro, Inc. (Issuer) CIK: 0001677077 (see all company filings)

EIN.: 811822909 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)